This is a StreetInsider.com Premium Only Page

Bio-Path Holdings (BPTH) – StreetInsider.com Reports

Apr 18, 2024 01:59 PM Bio-Path Holdings (BPTH) Announces 375K Share Offering at $3.225/sh

Apr 18, 2024 09:53 AM Roth/MKM Out Positive on Bio-Path Holdings (BPTH), PT $40

Apr 18, 2024 07:25 AM Bio-Path Holdings (BPTH) Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients

Apr 15, 2024 07:03 AM Bio-Path Holdings (BPTH) Expands Patent Portfolio

Apr 4, 2024 04:37 PM Bio-Path Holdings (BPTH) Enters ATM Agreement

Apr 2, 2024 10:50 AM Roth/MKM Reiterates $40 PT on Bio-Path Holdings (BPTH): 'Business Update Includes Developing Prexigebersen For Obesity'

Apr 2, 2024 07:04 AM Bio-Path Holdings (BPTH) Issues 2024 Update

Mar 13, 2024 05:08 PM Bio-Path Holdings (BPTH) Receives Nasdaq Non-compliance Notice

Feb 21, 2024 07:02 AM Bio-Path Holdings (BPTH) announce 1-for-20 reverse stock split

Nov 15, 2023 07:03 AM Bio-Path Holdings (BPTH) Tops Q3 EPS by 2c

Aug 15, 2023 07:01 AM Bio-Path Holdings (BPTH) Misses Q2 EPS by 9c

Aug 3, 2023 08:23 AM Bio-Path Holdings (BPTH) Prices 3.5M Share Offering at $0.60/sh

Aug 1, 2023 07:00 AM Bio-Path Holdings (BPTH) Reports Positive Results from Interim Analysis of Phase 2 Trial of Prexigebersen

May 12, 2023 07:09 AM Bio-Path Holdings (BPTH) Misses Q1 EPS by 20c

Mar 31, 2023 07:12 AM Bio-Path Holdings (BPTH) Misses Q4 EPS by 144c

Feb 3, 2023 04:16 PM Bio-Path Holdings (BPTH) Announces 800K Share Offering by Selling Stockholders

Nov 15, 2022 07:07 AM Bio-Path Holdings (BPTH) Misses Q3 EPS by 3c

Nov 7, 2022 07:01 AM Bio-Path Holdings (BPTH) Announces 800K Share Private Placement at $2.50/sh

Aug 16, 2022 07:54 AM Bio-Path Holdings (BPTH) Tops Q2 EPS by 8c

May 19, 2022 06:47 AM Bio-Path Holdings (BPTH) PT Lowered to $9 at H.C. Wainwright

Apr 12, 2022 04:02 PM Bio-Path Holdings (BPTH) Presents New BP1003 Data

Apr 6, 2022 07:04 AM Bio-Path Holdings (BPTH) Appoints Aline Sherwood to its Board

Mar 11, 2022 07:05 AM Bio-Path Holdings (BPTH) Reports FY21 Net Loss of $10.4M

Aug 24, 2021 07:06 AM Bio-Path Holdings (BPTH) Announces Clearance of Investigational New Drug Application for BP1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients

Jun 22, 2021 07:12 AM Bio-Path Holdings (BPTH) Granted Key Mechanism of Action U.S. Patent for BP1003

Apr 5, 2021 07:01 AM Bio-Path Holdings (BPTH) Announces Successful Completion of Safety Cohort of Triple Combination of Prexigebersen, Decitabine and Venetoclax in Stage 2 of Phase 2 Clinical Trial in Acute Myeloid Leukem

Mar 11, 2021 05:03 AM UPDATE: Roth Capital Starts Bio-Path Holdings (BPTH) at Buy

Feb 16, 2021 09:28 AM Pre-Open Stock Movers 02/16: (SCKT) (WBAI) (SESN) Higher; (BLUE) (HEPA) (BPTH) Lower (more...)

Feb 16, 2021 07:18 AM Bio-Path (BPTH) Announces Pricing of $13 Million Public Offering of Common Stock at $7.60/sh

Feb 10, 2021 07:15 AM Bio-Path Holdings (BPTH) Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology

Nov 19, 2020 07:07 AM Bio-Path Holdings (BPTH) Reports First Patient Dosed in Phase 1 Clinical Trial of BP1002

Oct 22, 2020 07:15 AM Bio-Path (BPTH) Receives Notice of Allowance for Strategic Patent for Prexigebersen in Combination with Front Line Cytidine Analogues or Bcr-Abl Tyrosine Kinase Inhibitors in Variety of Cancers

Aug 17, 2020 11:26 AM Bio-Path Holdings (BPTH) PT Lowered to $12 at H.C. Wainwright

May 18, 2020 07:54 AM Bio-Path Holdings (BPTH) PT Lowered to $18 at H.C. Wainwright

Jan 8, 2020 08:11 AM Bio-Path Holdings (BPTH) Provides Clinical Update and 2020 Business Outlook

Dec 2, 2019 07:38 AM Bio-Path Holdings (BPTH) PT Lowered to $25 at H.C. Wainwright

Nov 26, 2019 08:06 AM Bio-Path Holdings (BPTH) Reports Successful Completion of Safety Testing in Stage 2 of Phase 2 Clinical Trial in Acute Myeloid Leukemia

Nov 21, 2019 11:31 AM Bio-Path Holdings (BPTH) Halted on LUDP

Nov 21, 2019 11:30 AM Bio-Path Holdings (BPTH) Announces $8 Million Registered Direct Offering of Common Stock, Warrants Priced At-the-Market

Nov 21, 2019 08:06 AM Bio-Path Holdings (BPTH) Announces Clearance of IND Application for BP1002

Oct 15, 2019 08:16 AM Bio-Path Holdings (BPTH) Announces Martina Molsbergen to Board

Sep 25, 2019 08:07 AM Bio-Path Holdings (BPTH) Updates IP Portfolio with Addition of Recently Issued Second Platform Technology Patent

Aug 26, 2019 07:02 AM Bio-Path Holdings (BPTH) Reports Patient Dosing in Amended Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia

Jul 16, 2019 07:59 AM UPDATE: H.C. Wainwright Starts Bio-Path Holdings (BPTH) at Buy

May 17, 2019 09:27 AM Pre-Open Movers 05/17: (CRAY) (ACHN) (UA) Higher; (PINS) (BIDU) (IQ) (more...)

May 16, 2019 06:31 PM After-Hours Movers 05/16: (BOOT) (AMAT) (MNKD) Higher; (PINS) (BIDU) (BPTH) (more...)

Apr 3, 2019 08:05 AM Bio-Path Holdings (BPTH) Presents Preclinical Data at AACR

Mar 12, 2019 09:16 AM Bio-Path Holdings (BPTH) Sells ~713K Shares at $25.95/Sh in Registered Direct Offering

Mar 7, 2019 11:38 AM Bio-Path Holdings (BPTH) Halted Again on LUDP, Shares Up 362%

Mar 7, 2019 11:15 AM Bio-Path Holdings (BPTH) Halted on LUDP, Up 440%